Notably, Trop2 loss triggers sensitivity to anti-ErbB3 antibodies, which results in reduced proliferation and tumorigenic growth of Trop2 negative HNSCC cancer cells. This evidence concerns the gene ERBB3 and head and neck squamous cell carcinoma.